BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24900656)

  • 41. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man.
    Ryberg AT; Warfvinge G; Axelsson L; Soukup O; Götrick B; Tobin G
    Arch Oral Biol; 2008 Jan; 53(1):66-74. PubMed ID: 17825245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M
    Joseph L; Thomsen M
    Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. M1, M3 and M5 muscarinic receptors stimulate mitogen-activated protein kinase.
    Wotta DR; Wattenberg EV; Langason RB; el-Fakahany EE
    Pharmacology; 1998 Apr; 56(4):175-86. PubMed ID: 9566019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum.
    Takeuchi T; Fujinami K; Goto H; Fujita A; Taketo MM; Manabe T; Matsui M; Hata F
    J Neurophysiol; 2005 May; 93(5):2841-8. PubMed ID: 15574798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors.
    Lazareno S; Popham A; Birdsall NJ
    J Mol Neurosci; 2003; 20(3):363-7. PubMed ID: 14501021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4.
    Lazareno S; Farries T; Birdsall NJ
    Life Sci; 1993; 52(5-6):449-56. PubMed ID: 8441327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe.
    Gentry PR; Kokubo M; Bridges TM; Cho HP; Smith E; Chase P; Hodder PS; Utley TJ; Rajapakse A; Byers F; Niswender CM; Morrison RD; Daniels JS; Wood MR; Conn PJ; Lindsley CW
    ChemMedChem; 2014 Aug; 9(8):1677-82. PubMed ID: 24692176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. All muscarinic acetylcholine receptors (M
    Radu BM; Osculati AMM; Suku E; Banciu A; Tsenov G; Merigo F; Di Chio M; Banciu DD; Tognoli C; Kacer P; Giorgetti A; Radu M; Bertini G; Fabene PF
    Sci Rep; 2017 Jul; 7(1):5083. PubMed ID: 28698560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.
    Bymaster FP; Carter PA; Yamada M; Gomeza J; Wess J; Hamilton SE; Nathanson NM; McKinzie DL; Felder CC
    Eur J Neurosci; 2003 Apr; 17(7):1403-10. PubMed ID: 12713643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists.
    Richards MH; van Giersbergen PL
    Br J Pharmacol; 1995 Mar; 114(6):1241-9. PubMed ID: 7620715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of muscarinic receptor subtypes in acetylcholine release from urinary bladder obtained from muscarinic receptor knockout mouse.
    Takeuchi T; Yamashiro N; Kawasaki T; Nakajima H; Azuma YT; Matsui M
    Neuroscience; 2008 Oct; 156(2):381-9. PubMed ID: 18755247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists.
    Budzik B; Garzya V; Shi D; Walker G; Woolley-Roberts M; Pardoe J; Lucas A; Tehan B; Rivero RA; Langmead CJ; Watson J; Wu Z; Forbes IT; Jin J
    ACS Med Chem Lett; 2010 Sep; 1(6):244-8. PubMed ID: 24900202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite: demox, a modulator of orthosteric and allosteric sites at cardiac muscarinic M2 receptors.
    Angeli P; Marucci G; Buccioni M; Piergentili A; Giannella M; Quaglia W; Pigini M; Cantalamessa F; Nasuti C; Novi F; Maggio R; Qasem AR; Spampinato S
    Life Sci; 2002 Feb; 70(12):1427-46. PubMed ID: 11883718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres.
    Yang Q; Lachapelle EA; Kablaoui NM; Webb D; Popiolek M; Grimwood S; Kozak R; O'Connor RE; Lazzaro JT; Butler CR; Zhang L
    ACS Med Chem Lett; 2019 Jun; 10(6):941-948. PubMed ID: 31223452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.
    Zheng G; Smith AM; Huang X; Subramanian KL; Siripurapu KB; Deaciuc A; Zhan CG; Dwoskin LP
    J Med Chem; 2013 Feb; 56(4):1693-703. PubMed ID: 23379472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias.
    van der Westhuizen ET; Choy KHC; Valant C; McKenzie-Nickson S; Bradley SJ; Tobin AB; Sexton PM; Christopoulos A
    Front Pharmacol; 2020; 11():606656. PubMed ID: 33584282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.
    Zhang W; Basile AS; Gomeza J; Volpicelli LA; Levey AI; Wess J
    J Neurosci; 2002 Mar; 22(5):1709-17. PubMed ID: 11880500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Group II muscarinic acetylcholine receptors attenuate hepatic injury via Nrf2/ARE pathway.
    Luo L; Zhang G; Mao L; Wang P; Xi C; Shi G; Leavenworth JW
    Toxicol Appl Pharmacol; 2020 May; 395():114978. PubMed ID: 32234387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
    Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
    J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.